Table 3.
Agents | Details | Agents under investigation | Status | Ref. |
---|---|---|---|---|
Active immunotherapy agents (Vaccine) | DNA vaccine | pCMVE/MDC‐3Aβ11 PADRE‐C3d | – | 103 |
Epitope‐/protein‐/VLP‐based vaccine | Adeno‐10× Aβ3 – 10+ CpG | – | ||
Prime‐boost approach | Aβ1‐42 peptide prime/Aβ1‐42 DNA + QuilA | – | ||
Passive immunotherapy agents | Monoclonal antibody |
Bapineuzumab Solanezumab |
(III) | 64 |